Weekly obesity jab halves the risk of diabetes and can spark sufficient weight loss

An obesity drug given in weekly jabs more than halves the risk of developing type 2 diabetes, a landmark review suggests.
Patients can inject themselves with semaglutide, which works by hijacking th…
Read More

Shaun Wooller